Are tryptophan and 5-hydroxytryptophan effective treatments for depression?A meta-analysis

References

• Blazer D G, Kessler R C, McGonagle K A, Swartz M S. The prevalence and distribution of major depression in a national community sample. The National Comorbidity Survey. American Journal of Psychiatry 1994; 151: 979–986
   PubMed Web of Science ®Google Scholar
• McLennan W. Mental health and well-being: profile of Australian adults. Australian Bureau of Statistics, Canberra 1998
   Google Scholar
• Lader M, Herrington R. Drug treatment in psychiatry –psychotropic drugs. Handbook of Biological Psychiatry, H Praag, H Lader, O Rafaelsen, E Sachar. Marcel Dekker, New York 1981; 5
   Google Scholar
• Eisenberg D, Kessler R, Foster C, Norlock F, Calkins D, Delbanco T. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. New England Journal of Medicine 1993; 328: 246–252
   PubMed Web of Science ®Google Scholar
• MacLennan A, Wilson D, Taylor A. Prevalence and cost of alternative medicine in Australia. Lancet 1996; 347: 569–573
   PubMed Web of Science ®Google Scholar
• Eastwood H. Complementary therapies: the appeal to general practitioners. Medical Journal of Australia 2000; 173: 95–98
   PubMed Web of Science ®Google Scholar
• Lewith G. Complementary and alternative medicine: an educational, attitudinal and research challenge (editorial). Medical Journal of Australia 2000; 172: 102–103
   PubMed Web of Science ®Google Scholar
• Pirotta M V, Cohen M M, Kotsirilos V, Farish S. Complementary therapies: have they become accepted in general practice?. Medical Journal of Australia 2000; 172: 105–109
   PubMed Web of Science ®Google Scholar
• Jorm A, Korten A, Rodgers B, et al. Belief systems of the general public concerning the appropriate treatments for mental disorders. Social Psychiatry and Psychiatric Epidemiology 1997; 32: 468–473
   PubMed Web of Science ®Google Scholar
• Van Praag H. Management of depression with serotonin precursors. Biological Psychiatry 1981 1999; 16: 291–310
   Google Scholar
• Linde K, Mulrow C. St. John's wort for depression. (Cochrane Review). The Cochrane library, issue 4. Update Software, Oxford 1999
   Google Scholar
• Beckmann H, Kaspers S. Serotonin-Vorstufen als Antidepressiva: eine Ubersicht. Fortschritte neurologie und Psychiatrie 1983; 51: 176–182
   PubMed Web of Science ®Google Scholar
• Wurtman R, Fernstrom J. Control of brain neurotransmitter synthesis by precursor availability and nutritional state. Biochemical Pharmacology 1976; 25: 1691–1696
   PubMed Web of Science ®Google Scholar
• Wurtman R, Hefti F, Melamed E. Precursor control of neurotransmitter synthesis. Pharmacological Reviews 1981; 32: 315–335
   Web of Science ®Google Scholar
• Gelenberg A, Gibson C, Wojcik J. Neurotransmitter precursors for the treatment of depression. Psychopharmacology Bulletin 1982; 18: 7–18
   PubMedGoogle Scholar
• Murphy D, Campbell I, Costa J. Current status of the indolamine hypothesis of the affective disorders. Psychopharmacology: a generation of progress, R Lipton, M, DiMascio, A, Killam. Raven, New York 1978
   Google Scholar
• D'Elia G, Hanson L, Raotma H. L-Tryptophan and 5-hydroxytryptophan in the treatment of depression: a review. Acta Psychiatrica Scandinavica 1978; 57: 239–252
   PubMed Web of Science ®Google Scholar
• Toyo'oka T, Yamazaki T, Tanimoto T, et al. Characterization of contaminants in EMS-associated 1-tryptophan samples by high-performance liquid chromatography. Chemical and Pharmaceutical Bulletin 1991; 39: 820–822
   PubMed Web of Science ®Google Scholar
• Blackburn W. Eosinophilia Myalgia Syndrome. Seminars in Arthritis and Rheumatism 1997; 26: 781–784
   PubMed Web of Science ®Google Scholar
• Horowitz R, Daniels S. Bias or biology: evaluating the epidemiologic studies of 1-tryptophan and the eosinophilia–myalgia syndrome. Journal of Rheumatology 1996; 46: 81–88
   Google Scholar
• Michelson D, Page S, Casey R, et al. An eosinophilia–myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan. Journal of Rheumatology 1994; 21: 2261–2265
   PubMed Web of Science ®Google Scholar
• Van Praag J, Korf J, Dols L, Schut T. A pilot study of the predictive value of the probenecid test in application of 5-Hydroxytryptophan as antidepressant. Psychopharmacology 1972; 25: 14–21
   PubMed Web of Science ®Google Scholar
• Thomson J, Rankin H, Ashcroft G, Yates C, McQueen J, Cummings S. The treatment of depression in general practice: a comparison of L-Tryptophan, Amitriptyline, and a combination of L-Tryptophan and Amitriptyline with placebo. Psychological Medicine 1982; 12: 741–751
   PubMed Web of Science ®Google Scholar
• Sackett D L, Straus S E, Richardson W S, Rosenberg W, Haynes R B. Evidence-based medicine, 2nd edn. Churchill Livingstone, Edinburgh 2000
   Google Scholar